BE880043A - Compositions de cephradine et leurs procedes de preparation - Google Patents

Compositions de cephradine et leurs procedes de preparation

Info

Publication number
BE880043A
BE880043A BE0/198117A BE198117A BE880043A BE 880043 A BE880043 A BE 880043A BE 0/198117 A BE0/198117 A BE 0/198117A BE 198117 A BE198117 A BE 198117A BE 880043 A BE880043 A BE 880043A
Authority
BE
Belgium
Prior art keywords
cephradine
compositions
processes
preparation
cephradine compositions
Prior art date
Application number
BE0/198117A
Other languages
English (en)
French (fr)
Inventor
I Gibbs
A Lavia
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of BE880043A publication Critical patent/BE880043A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
BE0/198117A 1978-11-15 1979-11-14 Compositions de cephradine et leurs procedes de preparation BE880043A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/960,792 US4235900A (en) 1978-11-15 1978-11-15 Cephradine compositions

Publications (1)

Publication Number Publication Date
BE880043A true BE880043A (fr) 1980-05-14

Family

ID=25503637

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/198117A BE880043A (fr) 1978-11-15 1979-11-14 Compositions de cephradine et leurs procedes de preparation

Country Status (10)

Country Link
US (1) US4235900A (en:Method)
JP (1) JPS5572109A (en:Method)
AU (1) AU536346B2 (en:Method)
BE (1) BE880043A (en:Method)
CA (1) CA1128862A (en:Method)
DE (1) DE2945387A1 (en:Method)
FR (1) FR2441387A1 (en:Method)
GB (1) GB2035801B (en:Method)
IT (1) IT1127227B (en:Method)
ZA (1) ZA795624B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
CH660306A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
AT393452B (de) * 1985-08-05 1991-10-25 Bristol Myers Squibb Co Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
US6225304B1 (en) 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals
CN111595973A (zh) * 2020-05-30 2020-08-28 苏州必宜生物科技有限公司 一种液相色谱-串联质谱法测定血浆中头孢拉定浓度的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1291282A (en) * 1969-03-20 1972-10-04 Pfizer Ltd Improvements in pharmaceutical compositions
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
US3984403A (en) * 1972-06-30 1976-10-05 Takeda Chemical Industries, Ltd. Arginine and lysine salts of acid cephalosporins
ES412429A1 (es) * 1973-03-08 1976-01-01 Gallardo Antonio Sa Un procedimiento para la obtencion de sales de antibioticoscon aminoacidos de naturaleza basica.

Also Published As

Publication number Publication date
ZA795624B (en) 1980-10-29
GB2035801A (en) 1980-06-25
DE2945387A1 (de) 1980-06-04
FR2441387A1 (fr) 1980-06-13
DE2945387C2 (en:Method) 1993-01-07
FR2441387B1 (en:Method) 1983-01-07
IT7927288A0 (it) 1979-11-14
AU5206079A (en) 1980-05-22
GB2035801B (en) 1982-10-27
US4235900A (en) 1980-11-25
CA1128862A (en) 1982-08-03
AU536346B2 (en) 1984-05-03
IT1127227B (it) 1986-05-21
JPS5572109A (en) 1980-05-30

Similar Documents

Publication Publication Date Title
DE2962442D1 (de) Compositions photodurcissables
BE873479A (fr) Copolymeres organopolysiloxaniques polysequences cristallins et leurs procedes de preparation
FI793885A7 (fi) Tandkompositioner
BE880838A (fr) Composition thermochrome
NZ189574A (en) Dehydrocyclicimino acid derivatives pharmaceutical compositions
SE7910139L (sv) Mjukmedelshaltiga detergentkompositioner
BR7904031A (pt) Composicao tenso-ativa
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
FR2345439A1 (fr) Dihydrooxadiazinones et leurs procedes de preparation
IL56577A0 (en) Pharmaceutical compositions comprising certain pyrrolidinederivatives
SE7900413L (sv) Etbar komposition
PH18056A (en) Pharmaceutical formulations of cisplatin
BE880043A (fr) Compositions de cephradine et leurs procedes de preparation
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
FR2302102A1 (fr) Nouvelles substances antibiotiques derivees de l'antibiotique 67-694 et leurs procedes de preparation
GB2034587B (en) Pharmaceutical compositions
GB2016926B (en) Compositions comprising phosphite derivatives
FR2301511A1 (fr) Pentafluorsethylarylamines et leurs procedes de preparation
GB2039218B (en) Pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
NZ191048A (en) 1-benzoyl-3-pyridinyl-urea derivatives isecticidal compositions
GR64018B (en) Suspensives compositions of plants viruses
ZA794484B (en) Pharmaceutical compositions
ZA791032B (en) Pharmaceutical compositions
GB2031938B (en) Monoglyceride compositions

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: E.R. SQUIBB & SONS INC.

Effective date: 19991114